Order:
  1.  88
    Bullying in the U.S. Workplace: Normative and Process-Oriented Ethical Approaches.Helen LaVan & Wm Marty Martin - 2008 - Journal of Business Ethics 83 (2):147-165.
    Bullying is a serious problem in today’s workplace, in that, a large percentage of employees have either been bullied or knows someone who has. There are a variety of ethical concerns dealing with bullying—that is, courses of action to manage the bullying contain serious ethical/legal concerns. The inadequacies of legal protections for bullying in the U.S. workplace also compound the approaches available to deal ethically with bullying. While Schumann (2001, Human Resource Management Review 11, 93–111) does not explicitly examine bullying, (...)
    Direct download (4 more)  
     
    Export citation  
     
    Bookmark   12 citations  
  2.  19
    Domestic Violence Spillover into the Workplace: An Examination of the Difference between Legal and Ethical Requirements.Marsha Katz, Yvette P. Lopez & Helen LaVan - 2017 - Business and Society Review 122 (4):557-587.
    Domestic violence is a growing societal concern that often spills over into the workplace. However, employers are not recognizing the spillover of domestic violence as a workplace issue. This is problematic considering the serious financial, legal, and ethical consequences for organizations. We analyzed six cases involving domestic violence that were litigated under specific legal bases: Violence Against Women Act, discrimination laws including Title VII, Family and Medical Leave Act, Americans with Disabilities Act, Social Security Disability, Occupational Safety and Health Act, (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  3.  19
    A Framework for Understanding Ethical and Efficiency Issues in Pharmaceutical Intellectual Property Litigation.Margaret Oppenheimer, Helen LaVan & William F. Martin - 2015 - Journal of Business Ethics 132 (3):505-524.
    Developing and applying a framework for understanding the complexities of economic and legal considerations in two recent Supreme Court rulings was the focus of this research. Of especial concern was the protection of intellectual property in the pharmaceutical industry. Two cases from 2013 were selected: FTC v. Activis and Association for Molecular Pathology v. Myriad Genetics, Inc.. Part of the rationale for the selection was the importance of the Supreme Court rulings and the importance of the pharmaceutical sector. A qualitative (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   2 citations  
  4.  49
    An Ethical Analysis of the Second Amendment: The Right to Pack Heat at Work.William M. Martin, Helen LaVan, Yvette P. Lopez, Charles E. Naquin & Marsha Katz - 2014 - Business and Society Review 119 (1):1-36.
    We examine the issues concerning the legality and ethicality of the Second Amendment right to bear arms balanced by the employer's duty to provide a safe workplace for its employees. Two court rulings highlight this balancing act: McDonald et al. v. City of Chicago et al. and District of Columbia v. Heller. “Stand Your Ground” and “Castle Doctrine” laws in the recent Trayvon Martin shooting on February 26, 2012 are also applicable. Various ethical frameworks examine the firearms debate by viewing (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark   1 citation  
  5.  14
    An analysis of the ethical frameworks and financial outcomes of corporate social responsibility and business press reporting of US pharmaceutical companies.Ivana Zilic, Helen LaVan & Lori S. Cook - 2021 - International Journal of Business Governance and Ethics 1 (1):1.
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  6.  8
    Assessing UNGC pharmaceutical signatories stakeholders using big data.Ivana Zilic, Helen LaVan & Lori S. Cook - 2019 - Business and Society Review 124 (2):201-217.
    This article aims to focus on how signatories versus nonsignatories in the U.S. pharmaceutical sector compare with respect to the internal and external stakeholders and principles of the United Nations Global Compact (UNGC). We seek to answer the question: Do signatories to the UNGC walk the talk better than nonsignatories as determined by a variety of published rankings and data? This research presents an innovative approach to the evaluation of UNGC signatories. It uses several objective and independent data sources to (...)
    No categories
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark